Full-Time
Updated on 8/13/2026
Hybrid physical therapy services via telehealth
$90k - $105k/yr
No H1B Sponsorship
Manhattan, New York, NY, USA + 1 more
More locations: New York, NY, USA
Hybrid
Hybrid care includes in-home and virtual visits; travel within New York City boroughs via public transit is required and reimbursed.
MD
See people who can refer or advise you
Kins provides physical therapy through a hybrid model that blends in-person evaluations with telehealth sessions. Licensed physical therapists work as independent contractors to deliver personalized treatment plans, charging clients for sessions and consultations. The service uses technology to schedule and conduct remote visits, while maintaining U.S. data privacy standards. The company operates primarily in the United States and focuses on making physical therapy accessible and convenient for a diverse range of patients. Its approach differs from competitors by relying on a contractor network and a seamless mix of in-person and virtual care to tailor treatment to individual needs. The goal is to expand access to high-quality physical therapy across the U.S. while maintaining clear, data-protected care.
Company Size
51-200
Company Stage
Early VC
Total Funding
$18M
Headquarters
New York City, New York
Founded
2021
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Paid Holidays
Flexible Work Hours
Hybrid Work Options
Wysa today announced its acquisition of Kins, a U.S. physical therapy services company. The move addresses healthcare's notorious 17-year lag between clinica...
Wysa today announced its acquisition of Kins, a U.S. physical therapy services company.
Wysa, a mental health platform with an AI chatbot, has acquired the physical therapy startup Kins.
Wysa, a mental health platform with an AI chatbot, has bought physical therapy startup Kins, Endpoints News learned exclusively.
KINS, a healthcare startup, has secured funding in the first close of its Series C round from Towns Corporation. The two companies have also signed a basic agreement for a business alliance to develop new diagnostic technologies and preventive products focusing on the microbiome. The partnership aims to create innovative testing and intervention solutions for chronic diseases, leveraging KINS' expertise in microbiomes and Towns' diagnostic technology.